Shenzhen Hepalink Pharmaceutical Group Co · 002399
Fra 1 stk.
Markedsdata leveret af TwelveData og Morningstar
INVESTER I SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO MED ENDAVU: Køb Shenzhen Hepalink Pharmaceutical Group Co ($002399) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Shenzhen Hepalink Pharmaceutical Group Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a prominent pharmaceutical company specializing in the production and distribution of heparin and related products. Heparin, a critical anticoagulant, plays a vital role in medical treatments by preventing and treating blood clots. Shenzhen Hepalink is recognized for its comprehensive heparin production chain, from raw heparin sodium extraction to various formulated products, thereby ensuring high quality and consistency. The company extends its influence across diverse healthcare sectors, impacting hospitals, clinics, and other medical institutions worldwide. Headquartered in Shenzhen, China, it capitalizes on advancements in biotechnology and compliance with international health standards to maintain its competitive edge. By leveraging strong research and development initiatives, Shenzhen Hepalink contributes significantly to the pharmaceutical industry, driving innovation in anticoagulant therapies while expanding its market presence globally.
Baseret på 1 analytiker